{"id":"W3131318009","doi":"10.1016/j.jaci.2021.02.009","title":"Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment","year":2021,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver General Hospital","funders":"AstraZeneca","keywords":"Benralizumab; Placebo; Medicine; Exacerbation; Adverse effect; Asthma exacerbations; Asthma; Discontinuation; Internal medicine; Eosinophil; Mepolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006751737,0.0001738292,0.001002641,0.0001288258,0.0002692986,0.0004355951,0.0002025203,0.0005050472,0.0006162966],"category_scores_gemma":[0.001311552,0.00009726229,0.0008337132,0.0001509754,0.0001905054,0.0003229272,0.0001408494,0.000905673,0.0001277754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004372819,"about_ca_system_score_gemma":0.0005622625,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001431577,"about_ca_topic_score_gemma":0.002947359,"domain_scores_codex":[0.9996904,0.0001035179,0.00002300272,0.0000403357,0.0000523347,0.000090401],"domain_scores_gemma":[0.9992555,0.000226423,0.0002295362,0.00002999112,0.00006779798,0.0001907213],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.124931,0.005481806,0.5575659,0.000890371,0.002098615,0.001669912,0.0006482793,0.001089558,0.01210036,0.0002672245,0.002611213,0.2906458],"study_design_scores_gemma":[0.01372066,0.0604163,0.9121221,0.000331027,0.001733919,0.002364437,0.0005513364,0.001342803,0.002104529,0.0001477902,0.005123415,0.00004166475],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991177,0.008022636,0.0000448934,0.0001762836,0.00003679584,0.00001860186,0.00009023545,0.000005251602,0.0004283334],"genre_scores_gemma":[0.9979852,0.001429628,0.00005653428,0.0001548076,0.00003936929,0.00001373382,0.0001436575,0.000001479596,0.0001754678],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001431577,"threshold_uncertainty_score":0.003570676,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01384889164681728,"score_gpt":0.2924501968642371,"score_spread":0.2786013052174198,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}